Dilated cardiomyopathy in transgenic mice expressing HIV tat

Cardiovascular Toxicology

Volumn 9, Issue 1, 2009, Pages 39-45

  Fang, Qiujuan ^a   Kan, Hong ^a,b   Lewis, William ^d   Chen, Fangping ^a   Sharma, Puneet ^a   Finkel, Mitchell S ^a,b,c  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Beta adrenergic receptor; Contractility; Diastolic function; Heart failure model; Heart rate; Hemodynamics; Systolic function; Transgenic animals

Indexed keywords

ISOPRENALINE; TRANSACTIVATOR PROTEIN; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE; HEART RATE; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; IN VIVO STUDY; INOTROPISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; TRANSGENE; AGE; ANIMAL; BLOOD PRESSURE; DRUG EFFECT; GENETICS; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE PRESSURE; HEMODYNAMICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PATHOPHYSIOLOGY; TRANSGENIC MOUSE; VIROLOGY;

ANIMALIA; MUS; MUS MUSCULUS;

ADRENERGIC BETA-AGONISTS; AGE FACTORS; ANIMALS; BLOOD PRESSURE; BRADYCARDIA; CARDIOMYOPATHY, DILATED; HEART RATE; HEMODYNAMICS; HIV INFECTIONS; ISOPROTERENOL; MICE; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; MYOCARDIUM; RECEPTORS, ADRENERGIC, BETA; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 66849129132     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12012-009-9035-5     Document Type: Article

References (31)

1. Calasbrese, L. H., Proffitt, M. R., Yen-Lieberman, B., Hobbs, R. E., & Ratliff, N. B. (1987). Congestive cardiomyopathy and illness related to the acquired immunodeficiency syndrome (AIDS) associated with isolation of retrovirus from myocardium. Annals of Internal Medicine, 107(5), 691-692.
2. Stewart, J. M., Kaul, A., Gromisch, D. S., Reyes, E., Woolf, P. K., & Gowitz, M. H. (1989). Symptomatic cardiac dysfunction in children with human immunodeficiency virus infection. American Heart Journal, 117(1), 140-144. doi:10.1016/0002-8703(89) 90668-6.
3. Mirri, A., Rapezzi, C., Iacopi, F., Ortolani, P., Binetti, G., Fabbri, M., et al. (1990). Cardiac involvement in HIV infection: A prospective, multicenter clinical and echocardiographic study. Cardiologia (Rome, Italy), 35(3), 203-209.
4. Coudray, N., de Zuttere, D., Force, G., Champetier de Ribes, D., Pourny, J. C., Antony, I., et al. (1995). Left ventricular diastolic function in asymptomatic and symptomatic human immunodeficiency virus carriers: An echocardiographic study. European Heart Journal, 16(1), 61-67.
5. Barbaro, G., Barbarini, G., & Di Lorenzo, G. (1996). Early impairment of systolic and diastolic function in asymptomatic HIV-positive patients: A multicenter echocardiographic and echo-Doppler study. The Gruppo Italiano Per lo Studio Cardiologico dei Pazienti Affetti da AIDS. AIDS Research and Human Retroviruses, 12(16), 1559-1563. doi:10.1089/aid.1996.12.1559.
6. Cardoso, J. S., Moura, B., Martins, L., Mota-Miranda, A., Rocha Gonçalves, F., & Lecour, H. (1998). Left ventricular dysfunction in human immunodeficiency virus (HIV)-infected patients. International Journal of Cardiology, 63(1), 37-45. doi:10.1016/ S0167-5273(97)00276-283 (Pubitemid 28060224)
7. Barbaro, G., & Lipshultz, S. E. (2001). Pathogenesis of HIVassociated cardiomyopathy. Annals of the New York Academy of Sciences, 946, 57-81. Review.
8. Monsuez, J. J., Escaut, L., Teicher, E., et al. (2007). Cytokines in HIV-associated cardiomyopathy. International Journal of Cardiology, 120(2), 150-157. doi:10.1016/j.ijcard.2006.11.143. (Pubitemid 47049664)
9. Currie, P. F., Goldman, J. H., Caforio, A. L., et al. (1998). Cardiac autoimmunity in HIV related heart muscle disease. Heart (British Cardiac Society), 79(6), 599-604.
10. Buonaguro, L., Barillari, G., Chang, H. K., et al. (1992). Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. Journal of Virology, 66(12), 7159-7167.
11. Rerkpattanapipat, P., Wongpraparut, N., & Larry, E. (2000). Cardiac manifestations of acquired immunodeficiency syndrome. Archives of Internal Medicine, 160, 602-608. doi:10.1001/ archinte.160.5.602.
12. Kan, H., Xie, Z., & Finkel, M. S. (2000). HIV gp120 enhances NO production by cardiac myocytes through p38 MAP kinasemediated NF-KB activation. The American Journal of Physiology, 279, H3138-H3143.
13. Kan, H., Xie, Z., & Finkel, M. S. (2004). P38 MAP kinase mediated negative inotropic effect of HIV gp120 on cardiac myocytes. American Journal of Physiology Cell Physiology, 286(1), C1-C7. doi:10.1152/ajpcell.00059.2003.
14. Kan, H., Xie, Z., & Finkel, M. S. (2006). IPLA2 inhibitor blocks negative inotropic effect of HIV gp120 on cardiac myocytes. Journal of Molecular and Cellular Cardiology, 40(1), 131-137. doi:10.1016/j.yjmcc.2005.10.006. (Pubitemid 43012124)
15. Yuan, Y., Kan, H., Fang, Q., Chen, F., & Finkel, M. S. (2008). CXCR4 receptor antagonist blocks cardiac myocyte P38 MAP kinase phosphorylation by HIV gp120. Cardiovascular Toxicology, 8(4), 173-180. doi:10.1007/s12012-008-9026-y.
16. Chen, F., Shannon, K., Ding, S., Silva, M. E., Wetzel, G. T., Klitzner, T. S., et al. (2002). HIV type 1 glycoprotein 120 inhibits cardiac myocyte contraction. AIDS Research and Human Retroviruses, 18(11), 777-784. doi:10.1089/08892220260139512.
17. Raidel, S.M.,Haase, C., Jansen,N. R., & Lewis,W.(2002).Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage. American Journal of Physiology. Heart and Circulatory Physiology, 282(5), H1672-H1678.
18. Rana, T. M., & Jeang, K. T. (1999). Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA. Archives of Biochemistry and Biophysics, 365(2), 175-185. doi: 10.1006/abbi.1999.1206. (Pubitemid 29391624)
19. Pugliese, A., Vidotto, V., Beltramo, T., et al. (2005). A review of HIV-1 Tat protein biological effects. Cell Biochemistry and Function, 23(4), 223-227. doi:10.1002/cbf.1147. (Pubitemid 40992780)
20. Wang, Q., Brunner, H. R., & Burnier, M. (2004). Determination of cardiac contractility in awake unsedated mice with a fluidfilled catheter. American Journal of Physiology Heart and Circulatory Physiology, 286(2), H806-H814. doi:10.1152/ajpheart. 00291.2003.
21. Kan, H., & Finkel, M. S. (2003). Inflammatory mediators and reversible myocardial dysfunction. Journal of Cellular Physiology, 195, 1-11. doi:10.1002/jcp.10213. (Pubitemid 36297022)
22. Fan, G.-C., Zhou, X., Wang, X., Song, G., Qian, J., Nicolaou, P., et al. (2008). Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity. Circulation Research, 103, 1270-1279. doi:10.1161/ CIRCRESAHA.108.182832.
23. Singh, I. N., El-Hage, N., Campbell, M. E., et al. (2005). Differential involvement of p38 and JNK MAP kinases in HIV-1 Tat and gp120-induced apoptosis and neurite degeneration in striatal neurons. Neuroscience, 135(3), 781-790. doi:10.1016/ j.neuroscience.2005.05.028. (Pubitemid 41407741)
24. Liu, X., Jana, M., Dasgupta, S., et al. (2002). Human immunodeficiency virus type 1 (HIV-1) Tat induces nitric-oxide synthase in human astroglia. The Journal of Biological Chemistry, 277(42), 39312-39319. doi:10.1074/jbc. M205107200. (Pubitemid 35190903)
25. Fisher, S. D., Easley, K. A., Orav, E. J., Colan, S. D., Starc, T. J., Bricker, J. T., et al. (2005). Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: The prospective P2C2 HIV multicenter study. American Heart Journal, 150(3), 439-447. doi:10.1016/j.ahj.2005.06.012. (Pubitemid 41317610)
26. Twagirumukiza, M., Nkeramihigo, E., Seminega, B., Gasakure, E., Boccara, F., & Barbaro, G. (2007). Prevalence of dilated cardiomyopathy in HIV-infected African patients not receiving HAART: A multicenter, observational, prospective, cohort study in Rwanda. Current HIV Research, 5(1), 129-137. doi: 10.2174/157016207779316288. (Pubitemid 46062366)
27. Kristoffersen, U. S., Lebech, A. M., Gerstoft, J., Hesse, B., Petersen, C. L., Gutte, H., et al. (2008). Right and left cardiac function in HIV-infected patients investigated using radionuclide ventriculography and brain natriuretic peptide: A 5-year followup study. HIV Medicine, 9(3), 180-186. doi:10.1111/j.1468-1293. 2007.00531.x. (Pubitemid 351279574)
28. Khunnawat, C., Mukerji, S., Havlichek, D. Jr., Touma, R., & Abela, G. S. (2008). Cardiovascular manifestations in human immunodeficiency virus-infected patients. The American Journal of Cardiology, 102(5), 635-642. doi:10.1016/j.amjcard.2008. 04.035.
29. El Hattaoui, M., Charei, N., Boumzebra, D., Aajly, L., & Fadouach, S. (2008). Prevalence of cardiomyopathy in HIV infection: Prospective study on 158 HIV patients. Medecine et Maladies Infectieuses, 38(7), 387-391. doi:10.1016/j.medmal. 2008.03.006.
30. Otis, J. S., Ashikhmin, Y. I., Brown, L. S., & Guidot, D. M. (2008). Effect of HIV-1-related protein expression on cardiac and skeletal muscles from transgenic rats. AIDS Research and Therapy, 5, 8. doi:10.1186/1742-6405-5-8. (Pubitemid 351639012)
31. Fiala, M., Popik, W., Qiao, J. H., et al. (2004). HIV-1 induces cardiomyopathy by cardiomyocyte invasion and gp120, Tat, and cytokine apoptotic signaling. Cardiovascular Toxicology, 4(2), 97-107. doi:10.1385/CT:4:2:097. (Pubitemid 39310744)